IL-6 serum levels predict postoperative morbidity in gastric cancer patients.
Despite progress in surgical techniques and perioperative care, gastrectomy remains a procedure of significant morbidity. Several scoring systems and clinical measures have been adopted to predict postoperative complications in gastric cancer patients. The aim of this study was to investigate whether high serum levels of interleukin 6 (IL-6) in the early postoperative period may be a prognostic factor of postoperative morbidity.
Version: za2963e q8zab q8zbd q8zcc q8zd7 q8ze4 q8zfe q8zg6